Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer [Phase 3]
Phase 3 trial evaluating durvalumab with or without olaparib as maintenance therapy after first-line treatment for advanced or recurrent end…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 [Phase 1]
Phase 1 study of RP903 conducted by Risen (Suzhou) Pharma Tech Co., Ltd. has completed, evaluating safety, tolerability, pharmacokinetics, e…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr
This clinical trial update examines the prognostic role of molecular classification in fertility-sparing treatment of endometrial cancer. Th…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer [NA]
A completed clinical trial assessing how adjuvant chemotherapy affects quality of life in patients with stage II/III endometrial cancer, wit…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer [NA]
The trial evaluating adjuvant hypofractionated whole pelvis radiation therapy for endometrial cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. [Phase 2]
Phase 2 clinical trial update on retifanlimab, alone or in combination with other therapies, for advanced or metastatic endometrial cancer a…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line [Phase 3]
A Phase 3 clinical trial in MMR-deficient endometrial cancer is evaluating first-line chemotherapy versus dostarlimab. The study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients [Phase 3]
Phase 3 trial evaluating prevention and treatment of chemotherapy-induced nausea and vomiting in gynecologic cancer patients treated with th…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Serum Trace Element Levels in Some Gynecological Diseases [NA]
Clinical trial update from Cumhuriyet University indicates a completed study examining serum trace element levels in gynecological diseases,…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating REGN5668 with cemiplimab, cemiplimab plus fianlimab, or ubamatamab in adult women with ovarian cancer,…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Strive Cardio for Endometrial Cancer Survivors [NA]
The Strive Cardio trial for endometrial cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer [NA]
A clinical trial comparing OSNA and ultrastaging for detecting sentinel lymph node metastasis in endometrial cancer; recruitment is currentl…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
This completed study investigates the prevalence of HER2 IHC 3+ and characterizes clinicopathologic features of gynecologic cancers in Taiwa…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 [Phase 1, Phase 2]
A phase 1/2 trial evaluating afuresertib in combination with sintilimab and chemotherapy in selected solid tumors resistant to prior PD-1/PD…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer [Phase 2]
A Phase 2 trial is evaluating the combination of Nab-Sirolimus with Letrozole for advanced or recurrent endometrioid endometrial cancer. The…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors [Phase 1, Phase 2]
Phase I/II trial of autologous T cells engineered to express T-cell receptors (TCRs) in patients with solid tumors was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Study of ART0380 in Patients With Biologically Selected Solid Tumors [Phase 2]
A Phase 2 study of ART0380 in biologically selected solid tumors, including recurrent endometrial cancer, was terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer [Phase 1, Phase 2]
Phase I/II study evaluating VLS-1488 in adults with advanced cancer; the trial is currently recruiting across multiple solid-tumor indicatio…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors [Phase 2]
A Phase 2 trial evaluating niraparib in patients with advanced PALB2-mutated tumors was terminated; results have been posted for multiple so…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Physical Activity Promotion for Breast and Endometrial Cancer Survivors [NA]
A clinical trial evaluating a physical activity promotion program for breast and endometrial cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of stereotactic body radiation therapy for recurrent primary ovarian or uterine cancer…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer [EARLY_Phase 1]
This update reports the completion of a Phase 1 trial evaluating the combination of abemaciclib and letrozole in patients with endometrial c…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer [NA]
The study evaluating a de-escalated conformal radiation regimen with sequential chemotherapy for endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care [NA]
A completed clinical trial evaluating universal DNA sequencing of endometrial cancer to detect Lynch syndrome and guide personalized care fo…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety and anti-tumor activity of metronomic cyclophosphamide, metformin, and olaparib in patient…